Neuromeka Co., Ltd. (KOSDAQ:348340)
South Korea · Delayed Price · Currency is KRW 90,800
-7,200 (-7.35%)
At close: Feb 6, 2026
Neuromeka Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 18,654 | 24,784 | 13,743 | 9,755 | 7,351 | 4,066 |
Other Revenue | 485.88 | 485.88 | - | - | -0 | - |
| 19,140 | 25,269 | 13,743 | 9,755 | 7,351 | 4,066 | |
Revenue Growth (YoY) | -19.68% | 83.87% | 40.89% | 32.69% | 80.81% | -43.63% |
Cost of Revenue | 16,532 | 21,209 | 12,580 | 8,672 | 5,555 | 3,844 |
Gross Profit | 2,608 | 4,061 | 1,163 | 1,083 | 1,797 | 221.53 |
Selling, General & Admin | 11,065 | 11,597 | 8,285 | 6,211 | 2,935 | 2,804 |
Research & Development | 5,839 | 6,620 | 5,264 | 1,923 | 931.67 | 3,816 |
Amortization of Goodwill & Intangibles | 114.77 | 118.84 | 106.04 | 88.85 | 38.31 | 28.36 |
Other Operating Expenses | 536.07 | 485.04 | 253.64 | 242.51 | 123.31 | 194.65 |
Operating Expenses | 17,834 | 23,499 | 15,989 | 8,892 | 4,806 | 8,376 |
Operating Income | -15,226 | -19,439 | -14,825 | -7,809 | -3,009 | -8,154 |
Interest Expense | -5,298 | -4,929 | -2,050 | -292 | -532.95 | -481.31 |
Interest & Investment Income | 519.01 | 626.1 | 1,097 | 315.7 | 57.4 | 52.64 |
Earnings From Equity Investments | 0.09 | 24.55 | -27.31 | - | - | - |
Currency Exchange Gain (Loss) | 19.32 | 24.66 | 99.84 | 72.27 | 115.2 | -103.01 |
Other Non Operating Income (Expenses) | -140.84 | 6,472 | -2,150 | -487.07 | -3,201 | 415.12 |
EBT Excluding Unusual Items | -20,127 | -17,221 | -17,856 | -8,201 | -6,570 | -8,271 |
Gain (Loss) on Sale of Investments | 1.51 | 494.01 | 282.13 | - | - | - |
Gain (Loss) on Sale of Assets | -121.02 | 2.36 | -72.2 | - | -23.88 | - |
Pretax Income | -20,246 | -16,724 | -17,646 | -8,201 | -6,594 | -8,271 |
Income Tax Expense | 24.84 | 30.57 | 7.1 | - | - | - |
Net Income | -20,259 | -16,755 | -17,654 | -8,201 | -6,594 | -8,271 |
Net Income to Common | -20,259 | -16,755 | -17,654 | -8,201 | -6,594 | -8,271 |
Shares Outstanding (Basic) | 11 | 11 | 10 | 9 | 7 | 1 |
Shares Outstanding (Diluted) | 11 | 11 | 10 | 9 | 7 | 1 |
Shares Change (YoY) | 4.92% | 1.18% | 21.12% | 19.56% | 440.13% | 168.49% |
EPS (Basic) | -1836.68 | -1588.84 | -1693.82 | -953.00 | -916.23 | -6207.24 |
EPS (Diluted) | -1836.68 | -1589.00 | -1694.00 | -953.00 | -916.23 | -6207.24 |
Free Cash Flow | -22,356 | -35,625 | -42,925 | -11,008 | -1,267 | -4,121 |
Free Cash Flow Per Share | -2026.75 | -3378.29 | -4118.56 | -1279.29 | -175.97 | -3092.46 |
Gross Margin | 13.62% | 16.07% | 8.46% | 11.10% | 24.44% | 5.45% |
Operating Margin | -79.55% | -76.93% | -107.88% | -80.06% | -40.93% | -200.57% |
Profit Margin | -105.85% | -66.30% | -128.46% | -84.07% | -89.70% | -203.44% |
Free Cash Flow Margin | -116.80% | -140.98% | -312.34% | -112.85% | -17.23% | -101.35% |
EBITDA | -12,517 | -17,117 | -13,819 | -6,908 | -2,120 | -7,179 |
EBITDA Margin | -65.40% | -67.74% | -100.55% | -70.82% | -28.84% | -176.57% |
D&A For EBITDA | 2,709 | 2,322 | 1,007 | 901.29 | 888.92 | 975.59 |
EBIT | -15,226 | -19,439 | -14,825 | -7,809 | -3,009 | -8,154 |
EBIT Margin | -79.55% | -76.93% | -107.88% | -80.06% | -40.93% | -200.57% |
Advertising Expenses | - | 764.89 | 605.54 | 145.27 | 27.26 | 27.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.